Form 4 for HCA HCA Healthcare
Accepted 2021-11-10 00:00:00 ET · period of report 2021-11-08 · accession 0001209191-21-063964 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-10 | 2021-11-08 | HCA | Billington Phillip G | SVP-Internal Audit Services | F - Tax | $247.63 | -6,748 | 45.4K | -13% | -$1.67M |
| D | 2021-11-10 | 2021-11-08 | HCA | Billington Phillip G | SVP-Internal Audit Services | M - OptEx | $22.95 | +15.0K | 52.1K | +40% | +$344.2K |
| D | 2021-11-10 | 2021-11-10 | HCA | Billington Phillip G | SVP-Internal Audit Services | S - Sale+OE | $246.26 | -8,252 | 37.1K | -18% | -$2.03M |
| DM | 2021-11-10 | 2021-11-08 | HCA | Billington Phillip G | SVP-Internal Audit Services | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-08 | F | D | 6,748 | $247.63 | 45,361.43 | D | — | — | (F1) Includes 2,049.427 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2021-11-08 | M | A | 15,000 | $22.95 | 52,109.43 | D | — | — | (F1) Includes 2,049.427 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 3 | Common | Common Stock | 2021-11-10 | S | D | 8,252 | $246.26 | 37,109.43 | D | — | — | (F1) Includes 2,049.427 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. |
| 4 | Derivative | Stock Appreciation Right | 2021-11-08 | M | D | 7,500 | $0.00 | 0 | D | $22.95 · — to 2022-02-08 | 7,500 Common Stock | (F3) The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. |
| 5 | Derivative | Stock Appreciation Right | 2021-11-08 | M | D | 7,500 | $0.00 | 0 | D | $22.95 · — to 2022-02-08 | 7,500 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013. |